Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Schmook

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Oncology|January 31, 2020
Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic OpportunitiesJohannes Gojo, Zdenek Pavelka, Danica Zapletalova, et al.
Journal of Personalized Medicine|December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade GliomaLisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
Nature Cancer|February 17, 2026
M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumorsKyle S Smith, Tom T Fischer, Katie Han, et al.
Acta Neuropathologica|May 28, 2021
Targeting fibroblast growth factor receptors to combat aggressive ependymomaDaniela Lötsch, Dominik Kirchhofer, Bernhard Englinger, et al.
Neuro-Oncology|November 18, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimensAnna Laemmerer, Christian Lehmann, Lisa Mayr, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Oncology|January 31, 2020
Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic OpportunitiesJohannes Gojo, Zdenek Pavelka, Danica Zapletalova, et al.
Journal of Personalized Medicine|December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade GliomaLisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
Nature Cancer|February 17, 2026
M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumorsKyle S Smith, Tom T Fischer, Katie Han, et al.
Acta Neuropathologica|May 28, 2021
Targeting fibroblast growth factor receptors to combat aggressive ependymomaDaniela Lötsch, Dominik Kirchhofer, Bernhard Englinger, et al.
Neuro-Oncology|November 18, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimensAnna Laemmerer, Christian Lehmann, Lisa Mayr, et al.
Pageof 2